EQT

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

Noema Pharma AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company focuses on developing therapeutic products and therapies for orphan neurological disorders characterized by imbalanced neuronal networks. Its research and development efforts aim to address disabling symptoms in conditions affecting the nervous system, including Tuberous Sclerosis Complex, Trigeminal Neuralgia, and Tourette syndrome. By creating novel therapies, Noema Pharma seeks to improve the quality of life and patient outcomes for individuals suffering from these rare conditions.

NUA Surgical is an innovative start-up located at the Innovation Hub in Galway, Ireland, focused on enhancing women's health through advanced medical devices. The company has developed a patented surgical retractor specifically designed to improve the safety and efficiency of cesarean deliveries. By concentrating on research and development, NUA Surgical aims to provide obstetricians with tools that facilitate superior surgical outcomes, ultimately making C-sections safer for patients.

Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two primary business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring, owning, and managing a portfolio of electricity and gas meters, primarily smart meters, for energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, maintenance services, and ancillary support, such as customer service and call center operations, also on behalf of energy retailers. Calisen aims to capitalize on the UK government's initiative to roll out smart meters and is committed to supporting a cleaner and more sustainable energy sector by offering innovative services, including electric vehicle charging solutions. The company was incorporated in 2020.

Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

AMCS Group is an Irish company headquartered in Limerick, specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Founded in 2002 by James Martin and Austin Ryan, AMCS offers a comprehensive range of products, including RFID technology, weighing systems, and ERP software, which facilitate efficient management of operations such as bin, vehicle, and skip management. The company’s platform is designed to standardize and optimize business processes, enabling clients to reduce operating costs, enhance asset utilization, and improve customer service. AMCS Group serves a diverse clientele, including municipalities, private recycling firms, and commercial waste haulers, helping them transition towards a circular economy for better resource management and logistics.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.

Phagenesis Limited is focused on developing medical device technology aimed at treating dysphagia, a condition that impairs swallowing, often resulting from strokes or brain injuries. The company's primary product, Phagenyx, consists of a base station that delivers electrical stimulations to the patient and records pertinent information, along with a catheter that is introduced through the nose to stimulate the pharynx. This innovative approach leverages the brain's ability to relearn lost functions through neuroplasticity, effectively aiding patients in regaining control over their swallowing mechanisms. Founded in 2007 and based in Manchester, United Kingdom, Phagenesis emphasizes research and evidence-based solutions, with foundational work led by Professor Shaheen Hamdy of the University of Manchester, whose findings have been published in prestigious medical journals.

InstaVolt Ltd is a prominent provider of electric vehicle (EV) charging infrastructure in the United Kingdom, established in 2016 and headquartered in Basingstoke. The company focuses on the development, installation, ownership, and operation of rapid charging stations strategically located at retail and food sites, as well as fuel forecourts. By offering an open charger model, InstaVolt allows users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards, addressing concerns such as range anxiety that potential EV owners often face. The company aims to facilitate the transition to electric vehicles by making charging quick and accessible, thereby contributing to improved air quality and reduced carbon emissions across the UK. InstaVolt also provides landowners with opportunities to earn rental income by hosting their charging units, thereby fostering a collaborative approach to building the necessary infrastructure for a sustainable future.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

EQT is a global private equity and infrastructure firm founded in 1994, headquartered in Stockholm, Sweden. It specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies with strong growth potential. EQT invests across various sectors, including healthcare, technology, services, industrials, and real estate, with a particular emphasis on Northern and Eastern Europe, Asia, and the US. The firm seeks to unlock growth potential in its portfolio companies, positioning them as sustainable market leaders, and typically holds investments for four to eight years. EQT also prioritizes ESG and impact investments in its infrastructure portfolio.

SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.

Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

InstaVolt Ltd is a prominent provider of electric vehicle (EV) charging infrastructure in the United Kingdom, established in 2016 and headquartered in Basingstoke. The company focuses on the development, installation, ownership, and operation of rapid charging stations strategically located at retail and food sites, as well as fuel forecourts. By offering an open charger model, InstaVolt allows users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards, addressing concerns such as range anxiety that potential EV owners often face. The company aims to facilitate the transition to electric vehicles by making charging quick and accessible, thereby contributing to improved air quality and reduced carbon emissions across the UK. InstaVolt also provides landowners with opportunities to earn rental income by hosting their charging units, thereby fostering a collaborative approach to building the necessary infrastructure for a sustainable future.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.

Egle Therapeutics SAS is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing innovative immunotherapies that target immune suppressor regulatory T-cells (Tregs) for the treatment of oncology and autoimmune diseases. The company's research focuses on a proprietary drug pipeline that includes computationally designed IL-2 variants aimed at modulating Treg activity. This approach seeks to either engage or dis-engage Tregs, facilitating the development of therapies that can effectively combat cancer and other related conditions by addressing the immune suppression caused by Tregs. Egle Therapeutics aims to advance its unique portfolio to provide new treatment options in the healthcare field.

CFC Underwriting is the largest independent managing general agent (MGA) in the UK, specializing in providing insurance products through authorized brokers in over 60 countries. Catering to a diverse range of brokers, including wholesale, retail, generalist, and specialist firms, CFC offers access to underwriters capable of making swift decisions and delivering flexible solutions. The company is recognized for its market-leading products and exceptional service, supported by configurable online systems that enhance efficiency for its brokers. This commitment to quality has resulted in the acquisition of eight major industry awards in the past year, alongside the transition of over 1,500 businesses to CFC for their insurance needs each month.

Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

PRO Unlimited Inc. specializes in developing contingent workforce management solutions tailored for Global and Fortune 500 companies. Founded in 1991 and headquartered in Boca Raton, Florida, the company offers a vendor-neutral Managed Services Program that assists clients in effectively managing the procurement, selection, engagement, and tracking of various contingent workers, including independent contractors, consultants, and freelancers. PRO Unlimited also provides a software-as-a-service platform known as Vendor Management System (VMS), which centralizes the management of contingent workforce activities, statement of work engagements, and independent contractor utilization, thereby enhancing quality control, cost management, and compliance. Additionally, its RatePoint application delivers on-demand rate and hiring intelligence for professional contingent positions. The company's solutions address critical challenges such as supplier management, worker classification, lifecycle tracking, and 1099 management. With locations in the United Kingdom, Japan, California, New York, and Hong Kong, PRO Unlimited is well-positioned to meet the evolving needs of the contingent workforce marketplace.

Mollie is a payments platform based in Amsterdam, founded in 2004, that simplifies the integration of payment solutions for online businesses. Serving over 50,000 clients, the company supports a variety of local payment methods, including Mastercard, VISA, PayPal, and iDEAL, among others. Mollie's technology-driven approach allows merchants to easily implement payment systems through a simple yet powerful API, facilitating one-click payments, fraud monitoring, and real-time accounting. By streamlining the payment process, Mollie enables businesses to efficiently manage their finances and enhance revenue generation while minimizing operational complexities.

Solarpack is an independent solar photovoltaic power producer that specializes in the development and operation of large-scale solar projects. Established in 2005 and headquartered in Getxo, Vizcaya, Spain, the company offers a comprehensive range of services, including financing, construction, and management of utility-scale solar plants. With a total operational capacity of 160 MW across 13 plants and asset management services for an additional 302 MW, Solarpack has a diversified geographical presence, employing over 140 people in 10 countries. The company aims to contribute to sustainable energy infrastructure while fostering social development within the communities it serves by creating economic value and promoting quality employment through its initiatives.

Parcel2Go is a leading online parcel delivery service based in the UK, offering a comprehensive range of courier services for both home and business users. The company operates a parcel delivery comparison platform that provides customers with an alternative to traditional postal services. By partnering with major courier companies such as FedEx, UPS, and Hermes, Parcel2Go enables users to send packages of various sizes to destinations domestically and internationally. The platform allows customers to manage their orders online and track their shipments, ensuring a convenient and cost-effective delivery experience.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015. The company focuses on developing innovative solutions for treating rhinitis, including both allergic and non-allergic forms. It offers a single-use, minimally invasive device designed for ENT surgeons that utilizes radio-frequency technology to provide non-surgical interventions for chronic rhinitis. The device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it employs a microelectrode array to deliver targeted energy. This approach interrupts the autonomic function within the mucosal structures of the nasal cavities, effectively reversing the inflammatory process. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs associated with traditional surgical procedures.

Molslinjen is a privately held company specializing in ferry services between Jutland and the island of Zealand. The company operates domestic ferry lines and floating bridges, providing essential marine transportation services. Utilizing a fleet of catamaran ferries, Molslinjen facilitates efficient and comfortable travel for passengers, as well as vehicles such as cars, trucks, and buses. Its large car decks allow for easy boarding and disembarking, enhancing the overall travel experience. By prioritizing speed and convenience, Molslinjen plays a vital role in connecting regions and supporting local transportation needs.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Idealista operates an online property portal that serves agents and private individuals in Spain, Italy, and Portugal. The platform functions as a digital real estate marketplace, providing buyers and sellers with essential real-time information to facilitate property transactions. By offering a user-friendly interface, Idealista helps alleviate the challenges associated with finding a home, thus supporting millions of users in their real estate endeavors. Additionally, the company allows property owners to advertise their listings through a subscription model, enabling them to reach a broader audience while accessing valuable market insights.

Colisée is a prominent entity in the health care sector, specializing in the care and well-being of elderly individuals. The company operates over 90 retirement homes and nearly 70 home-based service agencies across France, Italy, and Spain. By focusing on both nursing home and home care services, Colisée provides essential daily care to residents and patients, as well as support for their families. With a workforce exceeding 6,700 employees, the organization is committed to delivering quality care tailored to the needs of the aging population.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Cybin is a biopharmaceutical company dedicated to advancing research and development in psychedelic and medicinal mushrooms. It focuses on creating safe and effective therapeutics for mental health issues, with an emphasis on psilocybin-based products. The company is actively launching these products in jurisdictions where they are permitted and is engaged in clinical studies across North America and other regions. Through strategic partnerships with academic and institutional entities, Cybin seeks to develop novel compounds and delivery mechanisms, aiming to provide innovative treatments for various psychiatric and neurological conditions.

Freepik Company, founded in 2010 and based in Málaga, Spain, provides an innovative digital platform that caters to the needs of designers and creative professionals. The company offers a vast library of over 250 million visual assets, including illustrations, photos, icons, mock-ups, and presentation templates, making it easier for users to access high-quality graphic resources for various applications such as websites, advertisements, and presentations. With a strong focus on integrating advanced generative AI technology, Freepik enhances content creation by enabling users to quickly transform ideas into audiovisual materials. The platform serves over 100 million users, including nearly 800,000 subscribers, and is committed to adapting to emerging design trends and technological advancements, thereby redefining the landscape of digital creativity.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company specializes in the development of innovative therapeutics for cancer treatment, specifically targeting key molecular pathways involved in DNA replication stress. By focusing on these novel pathways, FoRx Therapeutics aims to create first-in-class compounds that offer a new approach to targeted anticancer therapies. Through its research and development efforts, the company seeks to provide effective solutions in the fight against cancer.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.

WS Audiology A/S is a manufacturer and distributor of hearing instruments and audiological solutions, headquartered in Lynge, Denmark. Established in 2019 through a partnership between Sivantos and Widex, the company aims to enhance hearing care for individuals with hearing needs. Its product offerings include a comprehensive range of hearing aids, such as receiver-in-the-ear devices, assistive listening devices, and solutions for single-sided deafness. Additionally, WS Audiology provides accessories like hearing aid batteries, remote controls, and electronic drying stations. The company's diverse product spectrum caters to various price categories, ensuring that those with hearing loss have access to effective solutions for improved hearing and understanding.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

Veritas Petroleum Services is a global provider of testing, inspection, and advisory services, operating five laboratories strategically located in the Netherlands, Singapore, Houston, Fujairah, and Manchester. The company specializes in fuel quality testing, bunker quantity surveys, oil condition monitoring, and transformer oil testing, among other services. By offering these solutions, Veritas Petroleum Services assists clients in the marine, power, and renewable sectors to optimize their operational performance. The company focuses on helping its customers improve fuel management, reduce fuel costs, enhance operational efficiency, and comply with environmental regulations.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2015, the company is dedicated to creating first-in-class therapies aimed at selectively killing cancer cells. Artios's product pipeline features several promising programs, including a focus on DNA polymerase theta (Polθ), which plays a crucial role in DNA repair processes. Additionally, the company is advancing an in-licensed program that targets a newly identified protein linked to DDR and is developing a novel treatment aimed at DNA nucleases involved in these pathways. Artios collaborates with Cancer Research Technology and prominent DNA repair researchers globally to enhance its research and development efforts.

SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.

Azelis Group is a specialty chemicals distributor and innovation service provider that caters to the specialty chemicals and food ingredients industries. The company operates through several geographic segments, including EMEA, which encompasses Europe, the Middle East, and Africa; the Americas, which includes the United States, Canada, Mexico, and parts of South America; and Asia-Pacific, covering various countries in Asia and the Pacific region. Azelis leverages its extensive local knowledge and an international structure to offer a diverse range of products and services. The company emphasizes high levels of technical support and customized solutions to meet the specific needs of its clients. Its operations are supported by a corporate service center and headquarters located in Belgium.

MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

BBS Automation GmbH is a provider of automation solutions and engineering services, specializing in the design, development, manufacturing, and installation of automated assembly and testing systems. The company serves a diverse range of industries, including automotive, aerospace, life sciences, consumer goods, electronic devices, energy storage, and renewable energy. BBS Automation also offers leak detection, build-to-print services, and winding technology solutions, along with training and after-sales support. With nearly 550 employees, the company operates production sites in Germany, China, Malaysia, and the United States, partnering with prominent global clients. Founded in 1891 and headquartered in Garching bei München, Germany, BBS Automation is committed to delivering flexible and high-quality automation solutions for complex manufacturing and testing processes.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.

Orphazyme is a Copenhagen-based biopharmaceutical company focused on developing innovative therapies for lysosomal storage diseases, a group of serious genetic disorders. The company was founded on research conducted by Professor Marja Jäättela and Thomas Kirkegaard Jensen at the Danish Cancer Society. Orphazyme is engaged in biopharmaceutical research and development, and it has established collaborations with leading academic institutions in Europe and the United States. The company has also entered into a strategic partnership with CombiGene AB, further enhancing its capabilities in the field.

Caiway is a telecommunications infrastructure company based in the Netherlands, specializing in broadband services for over 350,000 households and businesses. The company has expanded its fiber network into remote areas, enhancing connectivity for municipalities and homes. As a regional internet service provider, Caiway offers a variety of services, including broadband, television, and telephony, delivered through its cable and fiber infrastructure. Major regions within Caiway's operational footprint include Westland, Schiedam, and Almelo, where it aims to provide reliable networking and high-quality service to its customers.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.

Two modern and strategically located office buildings in suburban Frankfurt.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Open Systems AG, established in 1990 and headquartered in Zurich, Switzerland, specializes in providing comprehensive managed security services to global enterprises, NGOs, and institutions. The company offers a range of services, including network security, application delivery, identity management, and global connectivity, ensuring secure and reliable IT networks and business-critical applications. Open Systems' offerings encompass distributed and enterprise firewall services, WAN encryption, network security monitoring, and incident response, among others. Serving diverse sectors such as finance, healthcare, and government, the company aims to deliver effective security solutions tailored to clients' unique needs.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

Innovyze is a global provider of software solutions focused on wet infrastructure business analytics, catering to the technological needs of water and wastewater utilities, government agencies, and engineering organizations. The company serves a diverse clientele, including major cities and foremost utilities across the UK, Australia, East Asia, and North America, as well as top-rated design firms worldwide. With a strong presence in North America, Europe, and the Asia Pacific, Innovyze offers a connected portfolio of advanced products that empower engineers to effectively plan, manage, design, protect, operate, and sustain efficient and reliable water infrastructure systems. This comprehensive approach ensures that its clients can achieve optimal performance and enduring success in their operations.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

GETEC is a group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company specializes in a comprehensive range of energy services within the liberalized energy market, focusing on areas such as energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing customized and sustainable solutions that prioritize efficiency, economic viability, and resource conservation. Its approach is centered on creating added value for clients, helping them to improve their carbon footprint while considering the long-term implications for future generations.

Adamo Telecom is a telecommunications operator based in Spain, specializing in ultra high-speed internet services through Fiber To The Home technology. The company provides internet access with speeds up to 1000 Mbit/s across various regions, including Catalonia, Valencia, Madrid, and Andalucía, among others. Adamo's network coverage extends to numerous provinces such as Alicante, Almería, Asturias, Barcelona, and Sevilla, ensuring connectivity even in remote areas. Originating from Sweden, Adamo aims to deliver high-quality fiber-based access networks and mobile and telephone services to both retail and wholesale subscribers across Europe.

GlobalConnect is a prominent alternative provider of fiber network, data center, and managed hosting services in Northern Europe, primarily focusing on Denmark and Germany. Established in 1998 by Niels Zibrandtsen, the company operates a 12,500 km optical fiber network and manages approximately 13,000 square meters of data center space. GlobalConnect offers a range of services including bandwidth connectivity, colocation, and cloud infrastructure, catering to both enterprises and consumers. With a workforce of over 200 employees, the company is dedicated to delivering fast and reliable networking solutions, enhancing connectivity and technological capabilities for its clients across Sweden, Norway, Denmark, Finland, and Northern Germany.

Independent Vetcare (IVC) is a privately owned veterinary services platform in the UK, boasting over 290 sites and an online pet pharmacy. With a workforce of approximately 2,700 full-time equivalents, including over 800 veterinarians, IVC is dedicated to providing high-quality care for pets across the country.

Fertin Pharma, headquartered in Vejle, Denmark, specializes in the development and production of innovative pharmaceutical and nutraceutical chewing gum products. The company is recognized as a leading B2B partner for nicotine chewing gum, collaborating with prominent global pharmaceutical firms. As a family-owned business with a deep-rooted history in chewing gum, Fertin Pharma manages all aspects of product development and manufacturing. Its extensive portfolio includes oral and intra-oral delivery systems designed to support healthier living, including extruded gum for Nicotine Replacement Therapy and applications in oral care, gastrointestinal health, pain management, and allergy relief. Fertin Pharma is committed to enhancing the effectiveness of active ingredients while ensuring an enjoyable consumer experience through effective taste masking and texture.

GETEC is a group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company specializes in a comprehensive range of energy services within the liberalized energy market, focusing on areas such as energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing customized and sustainable solutions that prioritize efficiency, economic viability, and resource conservation. Its approach is centered on creating added value for clients, helping them to improve their carbon footprint while considering the long-term implications for future generations.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

CHEP is a global provider of supply chain management solutions, specializing in the rental and maintenance of reusable containers, pallets, and other equipment. Its subsidiary, CHEP Aerospace Solutions, focuses on managing and repairing Unit Load Devices (ULDs), galley carts, and ground support equipment for the aviation industry. Headquartered in Zurich, Switzerland, CHEP Aerospace Solutions serves over 80 airlines worldwide, enabling them to concentrate on core operations while reducing costs and enhancing sustainability.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

TransIP Group B.V., established in 2003 and headquartered in Leiden, Netherlands, specializes in providing web hosting and related services. It caters primarily to tech-savvy customers and IT professionals, offering a range of products including virtual private servers, domain name registration, and web hosting. The company's notable services comprise BladeVPS PureSSD Pro, a self-managed tool with web control panels and operating systems, STACK for online file storage, syncing, and sharing, and SSL certificates for website encryption. Additionally, TransIP provides services like forwarding, big storage, and private network solutions. As of 2019, TransIP operates as a subsidiary of Combell nv.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

kfzteile24 GmbH is a German retailer specializing in automotive spare parts and accessories, operating primarily online through its platforms www.kfzteile24.de and www.autoteile24.de. Founded in 2001 and headquartered in Berlin, the company has established itself as one of the largest online auto parts retailers in Germany, achieving significant sales growth over the years. In addition to its online presence, kfzteile24 operates three physical retail stores that are affiliated with repair shops, enhancing its service offerings. The company provides a wide range of automotive products, including exhaust systems, batteries, and braking systems, and features a vehicle selection tool that facilitates the quick identification of required parts. Customers also benefit from in-house support from automotive experts who assist in finding suitable replacement parts at competitive prices.

Kuoni Reisen Holding AG is a Switzerland-based company that serves the travel industry and government sectors through three primary business activities. It operates Global Travel Distribution (GTD), which supplies hotel accommodations and destination services to travel companies and agents. The company also offers Global Travel Services (GTS), which coordinates comprehensive destination management services, including accommodation, transportation, tours, and event management. Additionally, Kuoni provides Visa Facilitation Services (VFS) through numerous application centers worldwide, assisting with visa outsourcing. The company further enhances its portfolio with Kuoni Destination Management, specializing in event development, budgeting, and creative direction, as well as providing entertainment and AV technology solutions for various events. This diverse range of services underscores Kuoni's commitment to delivering innovative and comprehensive travel and event solutions.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

kfzteile24 GmbH is a German retailer specializing in automotive spare parts and accessories, operating primarily online through its platforms www.kfzteile24.de and www.autoteile24.de. Founded in 2001 and headquartered in Berlin, the company has established itself as one of the largest online auto parts retailers in Germany, achieving significant sales growth over the years. In addition to its online presence, kfzteile24 operates three physical retail stores that are affiliated with repair shops, enhancing its service offerings. The company provides a wide range of automotive products, including exhaust systems, batteries, and braking systems, and features a vehicle selection tool that facilitates the quick identification of required parts. Customers also benefit from in-house support from automotive experts who assist in finding suitable replacement parts at competitive prices.

Kuros Biosciences AG is a biopharmaceutical company based in Schlieren, Switzerland, dedicated to the discovery, development, and commercialization of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has developed a robust pipeline of biopharmaceuticals targeting chronic diseases. Its key products include Neuroseal, a novel biomaterial for dural sealing, and the MagnetOs family of bone graft substitutes used in orthopedic, spinal, and dental applications. MagnetOs is approved for use in the EU and the US, with further formulations under development for regulatory submission. Kuros also has a range of clinical-stage products, including KUR-111 and KUR-113, which have completed Phase II clinical trials for treating specific bone fractures. The company has engaged in significant clinical research, enrolling over 600 patients in multinational trials, generating promising data regarding safety and efficacy in various applications, particularly within orthobiologics.

HusCompagniet A/S is a prominent house builder primarily operating in Denmark, with expanding activities in Sweden and Germany. The company specializes in the design, sale, and delivery of customizable single-family detached houses, which are largely constructed on-site on land owned by customers. Additionally, HusCompagniet offers semi-detached houses to both consumers and professional investors, and produces prefabricated wood-framed houses under the VårgårdaHus brand in Sweden. Headquartered in Horsens, Denmark, the company has established a strong market presence, being three times larger than its nearest competitor in Denmark. Since its incorporation in 2015, HusCompagniet has achieved significant revenue growth and has been recognized as House Builder of the Year in Denmark for three consecutive years, employing around 230 people and delivering over 1,000 houses annually across its markets.

Neuravi, established in 2009 and based in Galway, Ireland, specializes in the design and development of clot retrieval devices for treating acute ischemic strokes. The company's primary product, the EmboTrap revascularization device, is designed to restore blood flow by removing clots from blocked brain arteries. Neuravi operates in multiple European countries, collaborating with international researchers and clinicians to advance understanding and treatment of ischemic stroke. As of 2017, Neuravi operates as a subsidiary of DePuy Ireland Unlimited Company.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.